V-Square Quantitative Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

V-Square Quantitative Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.5K	Hold	162	–	–	﹤0.01%	617
2026 Q2	$39K	Buy	+162	New	+$35.5K	﹤0.01%	614
2024 Q2	–	Sell	-680	Closed	-$81.9K	–	593
2024 Q1	$81.9K	Hold	680	–	–	0.01%	545
2023 Q4	$83.6K	Buy	680 +265	+64%	+$33.1K	0.01%	545
2023 Q3	$53.7K	Buy	415 +64	+18%	+$8.53K	0.02%	494
2023 Q2	$43.5K	Buy	+351	New	+$47.2K	0.03%	311

Other funds holding JAZZ

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Poehling Capital Management Madison, Wisconsin $486M AUM 18.52% 1-Year Est. Return

V-Square Quantitative Management's JAZZ Position: Q3 2026 in Review

V-Square Quantitative Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 162 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #617.

V-Square Quantitative Management first reported a position in JAZZ in Q2 2023 and has held it in 6 quarters since. The position peaked at $83.6K in Q4 2023. 93 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

V-Square Quantitative Management held 162 shares of Jazz Pharmaceuticals worth $37.5K as of Q3 2026.
V-Square Quantitative Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of V-Square Quantitative Management's portfolio in Q3 2026, its #617 holding.
V-Square Quantitative Management first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
V-Square Quantitative Management's Jazz Pharmaceuticals position peaked at $83.6K in Q4 2023.
93 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.